Guardion Health Sciences Inc (NASDAQ:GHSI) shares traded up 3.7% on Thursday . The stock traded as high as $0.32 and last traded at $0.28, 483,497 shares changed hands during trading. A decline of 77% from the average session volume of 2,076,050 shares. The stock had previously closed at $0.27.

The company has a debt-to-equity ratio of 0.27, a current ratio of 0.35 and a quick ratio of 0.15. The firm has a 50 day simple moving average of $1.13.

Guardion Health Sciences (NASDAQ:GHSI) last released its quarterly earnings data on Monday, August 12th. The company reported ($0.14) earnings per share for the quarter. The company had revenue of $0.26 million for the quarter. Guardion Health Sciences had a negative return on equity of 282.34% and a negative net margin of 780.75%.

Guardion Health Sciences Company Profile (NASDAQ:GHSI)

Guardion Health Sciences, Inc, a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.

Featured Story: What is a Stop Order?

Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.